A trial evaluating pharmacokinetics of arhalofenate in subjects with renal impairment

Trial Profile

A trial evaluating pharmacokinetics of arhalofenate in subjects with renal impairment

Recruiting
Phase of Trial: Phase I

Latest Information Update: 11 Jan 2018

At a glance

  • Drugs Arhalofenate (Primary)
  • Indications Gout
  • Focus Pharmacokinetics
  • Sponsors Kowa Pharmaceuticals America
  • Most Recent Events

    • 11 Jan 2018 New trial record
    • 08 Jan 2018 According to a CymaBay Therapeutics media release, the company believed that data from this study has the potential to support enrollment criteria for phase III trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top